32 results
8-K
EX-10.1
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
by law and/or otherwise permitted by this Agreement.
By signing this Agreement, you waive any right to bring a lawsuit against the Released Parties
8-K
EX-10.2
KA
Kineta Inc
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
permitted by this Agreement.
By signing this Agreement, you waive any right to bring a lawsuit against the Released Parties and any right
8-K
EX-10.1
KA
Kineta Inc
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal … . In addition, if you file a lawsuit or other court proceeding against the Company for retaliating against you for reporting a suspected violation of law
8-K/A
EX-99.3
8lfbq
3 Feb 21
Other Events
4:59pm
8-K
EX-10.1
hhfjov06qv0l1jwj5v
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
fmvrydxo
9 Dec 20
Other Events
5:27pm
425
xdx9m2
9 Dec 20
Business combination disclosure
5:25pm
8-K
EX-99.1
uskou7o8exc0xw l5
4 Dec 20
Other Events
5:17pm
425
EX-99.1
qpyhax4q
4 Dec 20
Business combination disclosure
5:16pm
424B3
1ozk t4jw5c6e
12 Nov 20
Prospectus supplement
6:08am
S-4/A
8u9w3nl
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4/A
EX-10.21
9y0fvat4 la59
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm